v3.26.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Operating activities    
Net income $ 15,711 $ 7,723
Adjustments to reconcile net income to net cash used in operating activities:    
Share-based compensation 1,313 2,088
Depreciation and amortization 3,727 2,840
Loss from investments 2,484 68
Changes in expected credit losses on long-term financial assets 107 9
Inventory step-up recorded to cost of sales 0 517
Foreign currency gain (13,699) (1,583)
Other non-cash operating activities, net 979 779
Changes in operating assets and liabilities:    
Accounts receivable, net 879 (3,409)
Interest receivable 2,360 3,453
Other receivables 724 (2,379)
Prepaids and other current assets 3,310 (60)
Inventory, net (2,039) (1,631)
Accounts payable (1,206) (1,637)
Income taxes payable 1,387 4
Accrued liabilities (5,139) (8,878)
Net cash provided by (used in) operating activities 10,898 (2,096)
Investing activities    
Purchase of short-term investments 0 (40,000)
Proceeds from short-term investments 40,000 0
Purchase of property, plant and equipment (1,875) (15,258)
Purchase of intangible assets (96) (98)
Net cash provided by (used in) investing activities 38,029 (55,356)
Financing activities    
Repurchases of common stock (16,730) 0
Withholding taxes paid on share-based awards (1,538) (2,930)
Net cash used in financing activities (18,268) (2,930)
Effect of foreign currency translation on cash and cash equivalents (597) (604)
Net change in cash and cash equivalents 30,062 (60,986)
Cash and cash equivalents, beginning of period 791,794 858,805
Cash and cash equivalents, end of period 821,856 797,819
Supplemental cash flow information    
Interest paid 0 0
Interest received 9,370 13,052
Income taxes paid $ 8 $ 50